Andrea Glissmeyer Pmp, Csm, Bs Email & Phone Number

- Orchestrated the end-to-end development and deployment of a pioneering feature utilizing Intuit's IDX pipeline for a partner integration, valued at approximately $770K MRR, streamlining future integration builds with other partners.- Formulated and executed intricate project plans, encompassing scope definition, deliverables, risk assessments, milestone.

United States

- Developed and managed program plans for rare disease drug development clinical trials in partnership with CRO, Pharmaceutical, and drug development companies.- Data Driven Project Planning: Developed comprehensive plans outlining project scope, deliverables, risks, milestones, tracking, invoicing, budgeting, and reporting, ensuring financial viability.

Salt Lake City UT

- Standardized Project Delivery: Championed consistent project deliverables, working agreements, and adherence to EPMO standards for maximized efficiency.- Strategic Planning Leadership: Led senior leadership through a project to optimize quarterly planning, enhancing efficiency and stakeholder visibility across portfolios and programs.- Cross-Functional.

- Developed and maintained comprehensive program documentation to enable the successful identification, testing, and delivery of repurposed drug compounds for treatment of rare diseases and conditions without known market treatments.- Hybrid Methodology Expertise: Successfully managed projects using both Agile and Waterfall methodologies, adapting to.

Program manager with 20 direct reports. Managed the Incoming Inspection Quality Department ensuring the adherence to ISO and FDA medical device guidelines and BioFire’s Quality System. Reviewed and approved engineering drawings and specifications, and managed change management activities within the department. General supervisory skills including time card.

Greater Salt Lake City Area

Managed a multi-departmental product enhancement to add 3 new genes to the current testing panel, reducing production costs by 10%, reducing production TAT by 25%, and adding additional coverage to a current genetic testing panel to remain competitive in the market and provide more reliable testing to patients in need. Assisted in the initiating, planning.

Salt Lake City

-Assisted with the planning, documenting, executing, data analysis, and reporting of non-clinical trials performed for FDA PMA submission for the treatment of terminal cancer patients with experimental PARP inhibitor drug in collaboration with pharmaceutical companies-Responsible for the staffing, laboratory organization, process flow planning, equipment.

Myriad Genetics Salt Lake City, UT

-Assisted with the planning, documenting, executing, data analysis, and reporting of non-clinical trials performed for FDA PMA submission for the treatment of terminal cancer patients with experimental PARP inhibitor drug in collaboration with pharmaceutical companies-Data Analysis for use in PMA submission for FDA approval-Led area improvement projects to.

Patient Information managementReporting of patient results confidentially and accuratelyHCP paperwork preparation of test results and suggested treatments.